Posts Tagged ‘ adherence ’

Milliman Report on Value-Based Design and Diabetes

Tuesday, July 21st, 2009

Kathryn Fitch and the team at Milliman have produced this excellent report on the state of the value-based healthcare movement as it relates to diabetes management.  The analysis quantifies the projected costs associated with implementing VBID for diabetes drugs. Read

Research: Value-Based Design Boosts Diabetes Medication Adherence

Tuesday, June 9th, 2009

We’re pleased to highlight this new research demonstrating the positive results of value-based benefit design. Dr. Robert Scully, a board member of the Center for Health Value Innovation, is one of the people at the forefront of this research. Here’s …

CHVI President Commends Cigna and Merck

Monday, May 25th, 2009

CHVI President Cyndy Nayer is quoted in an article on HartfordBusiness.com, praising an unusual pay-for-performance contract between Cigna and Merck. The deal is this: Cigna gets discounts on Merck diabetes drugs Januvia and Janumet if covered patients take their drugs …